No Data
No Data
Aligos Therapeutics Announced Friday A Research Collaboration And Development Agreement With Xiamen Amoytop Biotech Co. Ltd. For Use Of Aligos' Oligonucleotide Platform For Treatment Of Liver Diseases
Aligos Therapeutics and Xiamen Amoytop Biotech Join Hands for the Treatment of Liver Diseases
Zhongji Innolight Nets $416 Million From Private Share Sale
One picture reads force core micro 2021 medium report
According to the report of Securities Star data Center, Lixin Wei2021 showed that the company's main income was 370 million yuan, up 64.78% from the same period last year; the net profit from its parent was 61.6072 million yuan, up 105.68% from the same period last year; deducting 57.7692 million yuan from non-net profit, up 130.52% from the same period last year; debt ratio 14.48%, investment income 1.6556 million yuan, financial expenses 1.4919 million yuan, gross profit 35.21%. There are 10 new shareholders in this period. CITIC Co., Ltd. holds 133683 shares, accounting for 1.03% of tradable shares, Guotai Junan Securities shares.
Suzhou Hengmingda Electronic Nets $53 Million in Private Share Sale
Read Heng Ming in a picture and read the China Daily in 2021.
According to the Securities Star data Center, Heng Mingda 2021 reported that the company's main income was 363 million yuan, up 65.52% from the same period last year; the net profit from its mother was 33.4027 million yuan, down 45.88% from the same period last year; deducting 22.497 million yuan from non-net profit, down 52.16% from the same period last year; debt ratio 17.65%, investment income 10.0048 million yuan, financial expenses 1,675,600 yuan, gross profit margin 28.51%. There is a total of 1 new shareholder in this period, China Industrial and Commercial Bank of China Co., Ltd.-China Europe value Smart return Hybrid Securities Investment Fund holds 818320 shares, accounting for the current